Entegris
ENTG
166.32
-0.57
-0.34%
Entegris
US · ENTG
#831 by market cap
Listed 1970
166.32
-0.57
-0.34%
Live - 5344 symbols - heartbeat 359s ago
· 2026-10-08 07:00
Pre-market
163.09
-1.94%
After-hours
167.05
+0.44%
Overnight
164.75
-0.94%
- Market cap
- 25.41B
- P/E (TTM)i
- 83.16
- P/Bi
- 6.11
- EPSi
- 1.55
- Div yieldi
- 0.24%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on ENTG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.4 percentage points.
Institutional ownership
- Held by institutions
- 109.31% -0.37pp
- Institutions
- 859 -3
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund92.89%
Public Company6.18%
Hedge Fund3.83%
Government Pension Fund1.85%
Private Company1.84%
Sovereign Wealth Fund1.50%
Family Office/Trust0.45%
VC/PE Fund0.44%
Individual/Insider0.37%
Top holders as of 2026-06-30
BlackRock
13.40% · 20.48M sh
T. Rowe Price Group, Inc.
8.39% · 12.82M sh
Capital Research
7.34% · 11.21M sh
Vanguard Capital Management, LLC
5.14% · 7.86M sh
Vanguard Portfolio Management, LLC
5.09% · 7.78M sh
Principal Global Investors, LLC
3.90% · 5.96M sh
State Street Global Advisors
3.61% · 5.52M sh
Invesco Ltd.
3.14% · 4.80M sh
J.P. Morgan Asset Management, Inc.
2.38% · 3.63M sh
PRIMECAP Management Company
2.05% · 3.13M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 17 buys · 33 sells
| Name | Role | Stake |
|---|---|---|
| Bertrand Loy | Chief Executive Officer | 0.15% |
| Susan Rice | Senior Vice President of Global Human Resources | 0.04% |
| Clinton Haris | Senior VP & President of Microcontamination Control | 0.04% |
| Daniel Woodland | Senior VP & President of Advanced Planarization Solutions | 0.02% |
| Azita Saleki | Independent Director | 0.02% |
| Joseph Colella | Senior VP, General Counsel, Chief Compliance Officer & Secretary | 0.01% |
| Neil Richards | Senior Vice President of Global Operations, Supply Chain & Quality | 0.01% |
| James Gentilcore | Lead Independent Director | 0.01% |
| James Lederer | Independent Director | 0.01% |
| Linda LaGorga | Senior Vice President | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-17 | David Reeder | Director | Sale to Issuer | -5,386 | $150.27 |
| 2026-08-13 | Olivier Blachier | Senior Vice President of Business & New Markets Development | Derivative Exercise and Sale | -2,000 | $80.71–160.66 |
| 2026-08-12 | Joseph Colella | Senior VP, General Counsel, Chief Compliance Officer & Secretary | Derivative Exercise and Sale | -3,916 | $98.11–164.48 |
| 2026-08-10 | Susan Rice | Senior Vice President of Global Human Resources | Open Market Disposition | -2,062 | $149.52 |
| 2026-08-02 | Robert Bruggeworth | Director | Other Acquisition | +1,329 | -- |
| 2026-06-10 | Linda LaGorga | Senior Vice President | Intent to Sell (Form 144) | -2,859 | $145.00 |
| 2026-06-02 | James Lederer | Independent Director | Open Market Disposition | -3,569 | $143.59 |
| 2026-05-26 | Clinton Haris | Senior VP & President of Microcontamination Control | Derivative Exercise and Sale | -6,848 | $98.11–149.23 |
| 2026-05-25 | Linda LaGorga | Senior Vice President | Intent to Sell (Form 144) | -2,860 | $140.00 |
| 2026-05-21 | Linda LaGorga | Senior Vice President | Intent to Sell (Form 144) | -2,389 | $135.00 |
| 2026-05-17 | Sukhi Nagesh | Chief Financial Officer | Other Acquisition | +8,254 | -- |
| 2026-05-14 | Susan Rice | Senior Vice President of Global Human Resources | Open Market Disposition | -6,933 | $133.01 |
| 2026-05-14 | Susan Rice | Senior Vice President of Global Human Resources | Derivative Exercise and Sale | -12,960 | $55.72–132.75 |
| 2026-05-13 | Clinton Haris | Senior VP & President of Microcontamination Control | Derivative Exercise and Sale | -5,830 | $55.72–144.57 |
| 2026-05-13 | Joseph Colella | Senior VP, General Counsel, Chief Compliance Officer & Secretary | Derivative Exercise and Sale | -6,326 | $80.71–140.25 |
| 2026-05-13 | Olivier Blachier | Senior Vice President of Business & New Markets Development | Derivative Exercise and Sale | -2,000 | $80.71–140.04 |
| 2026-05-05 | James Gentilcore | Lead Independent Director | Other Acquisition | +1,412 | -- |
| 2026-05-05 | Mary Puma | Independent Director | Other Acquisition | +1,412 | -- |
| 2026-05-05 | James Lederer | Independent Director | Other Acquisition | +1,412 | -- |
| 2026-05-05 | Yvette Gordon-Kanouff | Independent Director | Other Acquisition | +1,412 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:00:16 · For reference only, not investment advice and not tailored to your situation.